Lymphokine and synthesis of complement by guinea pig spleen cells. 1978

A Cambier, and A P Peltier

Lymphokine preparations have been obtained from normal guinea pig spleen cells stimulated in vitro by optimal doses of insoluble Concanavalin A. The biological activity of these preparations was estimated by Macrophage Inhibition Tests performed with peritoneal cells from identical guinea pigs. Addition of these preparations to culture of normal adherent guinea pig spleen cells, gives rise to a dose related inhibition of the normal synthesis of C2, the second component of the complement system, by these latter cells. This inhibition of synthesis, appears to be due to a functional effect of lymphokine on C2-producing cells and not to a cytotoxic effect. Preliminary results indicate that the same lymphokine preparations can have a stimulatory rather than an inhibitory effect on synthesis of haemolytic C1 by the same cells.

UI MeSH Term Description Entries
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D008297 Male Males
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003172 Complement C1 The first complement component to act in the activation of CLASSICAL COMPLEMENT PATHWAY. It is a calcium-dependent trimolecular complex made up of three subcomponents: COMPLEMENT C1Q; COMPLEMENT C1R; and COMPLEMENT C1S at 1:2:2 ratios. When the intact C1 binds to at least two antibodies (involving C1q), C1r and C1s are sequentially activated, leading to subsequent steps in the cascade of COMPLEMENT ACTIVATION. C1 Complement,Complement 1,Complement Component 1,C1, Complement,Complement, C1,Component 1, Complement
D003175 Complement C2 A component of the CLASSICAL COMPLEMENT PATHWAY. C2 is cleaved by activated COMPLEMENT C1S into COMPLEMENT C2B and COMPLEMENT C2A. C2a, the COOH-terminal fragment containing a SERINE PROTEASE, combines with COMPLEMENT C4B to form C4b2a (CLASSICAL PATHWAY C3 CONVERTASE) and subsequent C4b2a3b (CLASSICAL PATHWAY C5 CONVERTASE). C2 Complement,Complement 2,Complement Component 2,C2, Complement,Complement, C2,Component 2, Complement
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.

Related Publications

A Cambier, and A P Peltier
October 1986, Microbial pathogenesis,
A Cambier, and A P Peltier
August 1983, Biulleten' eksperimental'noi biologii i meditsiny,
A Cambier, and A P Peltier
January 1981, Journal of the National Cancer Institute,
A Cambier, and A P Peltier
April 1968, Journal of immunology (Baltimore, Md. : 1950),
A Cambier, and A P Peltier
February 1980, Journal of immunology (Baltimore, Md. : 1950),
A Cambier, and A P Peltier
February 1975, Journal of immunology (Baltimore, Md. : 1950),
A Cambier, and A P Peltier
October 1966, Proceedings of the National Academy of Sciences of the United States of America,
A Cambier, and A P Peltier
January 1991, Advances in prostaglandin, thromboxane, and leukotriene research,
A Cambier, and A P Peltier
February 1971, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!